贝利尤单抗-话题@MedSci

#贝利尤单抗#

7篇内容 | 1611人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2236897, encodeId=3d26223689e71, content=<a href='/topic/show?id=cd2892215bb' target=_blank style='color:#2F92EE;'>#贝利尤单抗#</a> <a href='/topic/show?id=17bc1212e40e' target=_blank style='color:#2F92EE;'>#先天和适应性免疫方面#</a>, objectTitle=Ann Rheum Dis：贝利尤单护对系统性红斑狼疮患者血液转录组的调控作用及早期疗效预测, objectType=article, longId=851136, objectId=239085113677, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240625/1719297072897_92910.jpg, objectUrl=/article/show_article.do?id=239085113677, replyNumber=0, likeNumber=10, createdTime=2024-11-14, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=239085113677, moduleTitle=Ann Rheum Dis：贝利尤单护对系统性红斑狼疮患者血液转录组的调控作用及早期疗效预测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=239085113677)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2226891, encodeId=25a422268916a, content=<a href='/topic/show?id=cd2892215bb' target=_blank style='color:#2F92EE;'>#贝利尤单抗#</a> <a href='/topic/show?id=8d95109e27ef' target=_blank style='color:#2F92EE;'>#系统性红斑狼疮(SLE)#</a>, objectTitle=Arthritis Res Ther：贝利尤单抗在系统性红斑狼疮治疗中的疗效和安全性分析——基于真实世界的回顾性研究, objectType=article, longId=843949, objectId=33b884394945, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240919/1726758269901_5485250.jpg, objectUrl=/article/show_article.do?id=33b884394945, replyNumber=0, likeNumber=17, createdTime=2024-09-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=33b884394945, moduleTitle=Arthritis Res Ther：贝利尤单抗在系统性红斑狼疮治疗中的疗效和安全性分析——基于真实世界的回顾性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33b884394945)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2211351, encodeId=9b352211351d6, content=<a href='/topic/show?id=7a056349485' target=_blank style='color:#2F92EE;'>#母乳#</a> <a href='/topic/show?id=cd2892215bb' target=_blank style='color:#2F92EE;'>#贝利尤单抗#</a>, objectTitle=Lupus Sci Med：病例报告——系统性红斑狼疮女性患者皮下注射贝利尤单抗后乳汁中贝利尤单抗浓度的变化, objectType=article, longId=831526, objectId=79e2831526dd, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240624/1719199793928_92910.jpg, objectUrl=/article/show_article.do?id=79e2831526dd, replyNumber=0, likeNumber=48, createdTime=2024-06-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=79e2831526dd, moduleTitle=Lupus Sci Med：病例报告——系统性红斑狼疮女性患者皮下注射贝利尤单抗后乳汁中贝利尤单抗浓度的变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79e2831526dd)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2140709, encodeId=04282140e0920, content=<a href='/topic/show?id=cd2892215bb' target=_blank style='color:#2F92EE;'>#贝利尤单抗#</a>治疗<a href='/topic/show?id=77e66814e1f' target=_blank style='color:#2F92EE;'>#狼疮性肾炎#</a>的疗效和安全性, objectTitle=Ren Fail：贝利尤单抗治疗狼疮性肾炎的疗效和安全性：系统回顾和荟萃分析, objectType=article, longId=775015, objectId=d78de750157a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230504/1683220015052_4754896.png, objectUrl=/article/show_article.do?id=d78de750157a, replyNumber=0, likeNumber=104, createdTime=2023-06-04, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=d78de750157a, moduleTitle=Ren Fail：贝利尤单抗治疗狼疮性肾炎的疗效和安全性：系统回顾和荟萃分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d78de750157a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2140710, encodeId=7a542140e1054, content=<a href='/topic/show?id=3469e71246f' target=_blank style='color:#2F92EE;'>#红斑狼疮#</a>：<a href='/topic/show?id=cd2892215bb' target=_blank style='color:#2F92EE;'>#贝利尤单抗#</a> PK <a href='/topic/show?id=e48b650540c' target=_blank style='color:#2F92EE;'>#泰它西普#</a>, objectTitle=红斑狼疮：贝利尤单抗 PK 泰它西普，谁能胜出？, objectType=article, longId=190856, objectId=c3a119085698, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20200319/812bc60981104d03b94bf7c1bab9318a.jpg, objectUrl=/article/show_article.do?id=c3a119085698, replyNumber=0, likeNumber=97, createdTime=2023-06-04, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c3a119085698, moduleTitle=红斑狼疮：贝利尤单抗 PK 泰它西普，谁能胜出？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3a119085698)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1516257, encodeId=6a74151625e2e, content=<a href='/topic/show?id=cd2892215bb' target=_blank style='color:#2F92EE;'>#贝利尤单抗#</a>, objectTitle=贝利尤单抗是如何战狼的？背后原来还有这么多细节......., objectType=article, longId=734460, objectId=b12be3446085, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b12be3446085, replyNumber=0, likeNumber=80, createdTime=2022-08-06, rootId=0, userName=ms1692810954239974, userId=9a4f10942480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b12be3446085, moduleTitle=贝利尤单抗是如何战狼的？背后原来还有这么多细节......., moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b12be3446085)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1516256, encodeId=c79015162568f, content=<a href='/topic/show?id=cd2892215bb' target=_blank style='color:#2F92EE;'>#贝利尤单抗#</a>, objectTitle=GSK贝利尤单抗新适应症获批, objectType=article, longId=204300, objectId=6d47204300dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d47204300dd, replyNumber=0, likeNumber=76, createdTime=2020-12-09, rootId=0, userName=ms1692810954239974, userId=9a4f10942480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d47204300dd, moduleTitle=GSK贝利尤单抗新适应症获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d47204300dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1516255, encodeId=075c151625563, content=<a href='/topic/show?id=cd2892215bb' target=_blank style='color:#2F92EE;'>#贝利尤单抗#</a>, objectTitle=全球且**！GSK生物制剂*倍力腾（化学名：贝利尤单抗）二度参展进博会，为系统性红斑狼疮儿童患者带来希望, objectType=article, longId=203030, objectId=584520303009, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=584520303009, replyNumber=0, likeNumber=81, createdTime=2020-11-08, rootId=0, userName=ms1692810954239974, userId=9a4f10942480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=584520303009, moduleTitle=全球且**！GSK生物制剂*倍力腾（化学名：贝利尤单抗）二度参展进博会，为系统性红斑狼疮儿童患者带来希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=584520303009)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1516254, encodeId=41d51516254c7, content=<a href='/topic/show?id=cd2892215bb' target=_blank style='color:#2F92EE;'>#贝利尤单抗#</a>, objectTitle=红斑狼疮：贝利尤单抗 PK 泰它西普，谁能胜出？, objectType=article, longId=190856, objectId=c3a119085698, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3a119085698, replyNumber=0, likeNumber=86, createdTime=2020-03-27, rootId=0, userName=ms1692810954239974, userId=9a4f10942480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3a119085698, moduleTitle=红斑狼疮：贝利尤单抗 PK 泰它西普，谁能胜出？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3a119085698)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1516253, encodeId=bde5151625325, content=<a href='/topic/show?id=cd2892215bb' target=_blank style='color:#2F92EE;'>#贝利尤单抗#</a>, objectTitle=葛兰素史克宣布贝利尤单抗治疗狼疮性肾炎患者的III期临床试验取得整体阳性结果, objectType=article, longId=184997, objectId=556218499e7a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=556218499e7a, replyNumber=0, likeNumber=74, createdTime=2019-12-22, rootId=0, userName=ms1692810954239974, userId=9a4f10942480, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=556218499e7a, moduleTitle=葛兰素史克宣布贝利尤单抗治疗狼疮性肾炎患者的III期临床试验取得整体阳性结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=556218499e7a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

贝利尤单抗

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#贝利尤单抗# #先天和适应性免疫方面#

Ann Rheum Dis：贝利尤单护对系统性红斑狼疮患者血液转录组的调控作用及早期疗效预测

2024-11-14发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#贝利尤单抗# #系统性红斑狼疮(SLE)#

Arthritis Res Ther：贝利尤单抗在系统性红斑狼疮治疗中的疗效和安全性分析——基于真实世界的回顾性研究

2024-09-21发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#母乳# #贝利尤单抗#

Lupus Sci Med：病例报告——系统性红斑狼疮女性患者皮下注射贝利尤单抗后乳汁中贝利尤单抗浓度的变化

2024-06-24发表于上海

侠胆医心 (审核中...)

前往app查看评论内容

#贝利尤单抗#治疗#狼疮性肾炎#的疗效和安全性

Ren Fail：贝利尤单抗治疗狼疮性肾炎的疗效和安全性：系统回顾和荟萃分析

2023-06-04发表于上海

侠胆医心 (审核中...)

前往app查看评论内容

#红斑狼疮#：#贝利尤单抗# PK #泰它西普#

红斑狼疮：贝利尤单抗 PK 泰它西普，谁能胜出？

2023-06-04发表于上海

ms1692810954239974 (审核中...)

前往app查看评论内容

#贝利尤单抗#

贝利尤单抗是如何战狼的？背后原来还有这么多细节.......

2022-08-06

ms1692810954239974 (审核中...)

前往app查看评论内容

#贝利尤单抗#

GSK贝利尤单抗新适应症获批

2020-12-09

ms1692810954239974 (审核中...)

前往app查看评论内容

#贝利尤单抗#

全球且**！GSK生物制剂*倍力腾（化学名：贝利尤单抗）二度参展进博会，为系统性红斑狼疮儿童患者带来希望

2020-11-08

ms1692810954239974 (审核中...)

前往app查看评论内容

#贝利尤单抗#

红斑狼疮：贝利尤单抗 PK 泰它西普，谁能胜出？

2020-03-27

ms1692810954239974 (审核中...)

前往app查看评论内容

#贝利尤单抗#

葛兰素史克宣布贝利尤单抗治疗狼疮性肾炎患者的III期临床试验取得整体阳性结果

2019-12-22

科室
- - 订阅+
  - 更多科室
工具
服务